SBC Medical Group (SBC) Projected to Release Quarterly Earnings on Friday

SBC Medical Group (NASDAQ:SBC) is anticipated to release its Q3 2026 results before the market opens on Friday, November 13th. Analysts expect the company to post earnings of $0.11 per share and revenue of $48.90 million for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Friday, November 13, 2026 at 8:30 AM ET.

SBC Medical Group (NASDAQ:SBC) last issued its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. The business had revenue of $49.19 million for the quarter, compared to analyst estimates of $45.37 million. On average, analysts expect SBC Medical Group to post $0.44 EPS for the current fiscal year and $0.52 EPS for the next fiscal year.

SBC Medical Group Stock Up 0.6%

SBC opened at $5.29 on Wednesday. SBC Medical Group has a 12 month low of $2.78 and a 12 month high of $5.79. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The stock has a market cap of $544.08 million, a P/E ratio of 11.19, a P/E/G ratio of 2.36 and a beta of 0.52. The stock’s 50 day moving average price is $5.02 and its 200 day moving average price is $3.95.

Analyst Ratings Changes

Several research firms have recently issued reports on SBC. Wall Street Zen raised SBC Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Monday, October 5th. BTIG Research reaffirmed a “buy” rating and issued a $8.00 price objective on shares of SBC Medical Group in a report on Thursday, August 13th. Finally, Weiss Ratings upgraded shares of SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $8.00.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated is a Japan-based healthcare services company focused on supporting aesthetic medicine and related medical institutions. Through its group companies, the business provides operational and management support designed to help clinics deliver cosmetic surgery, dermatology, and other elective medical services. The company’s services include clinic management consulting, marketing, staff recruitment and training, procurement, information technology, and administrative support.